Menus Subscribe Search

Follow us


gmo-protest

(PHOTO: JUSTASC/SHUTTERSTOCK)

The Scientific Debate About GM Foods Is Over: They’re Safe

• September 24, 2013 • 10:00 AM

(PHOTO: JUSTASC/SHUTTERSTOCK)

Now it’s time to have a better public debate.

It’s no secret that people are nervous about foods made from genetically modified organisms. A July Gallup poll found that 48 percent of respondents believed that GM foods “pose a serious health hazard,” compared to 36 percent who didn’t. California voters may have rejected a ballot initiative to require labeling of GM foods last fall, but a New York Times survey found overwhelming support for mandatory labeling on the packaging of GM foods.

Within the scientific community, the debate over the safety of GM foods is over. The overwhelming conclusion is, in the words of the American Association for the Advancement of Science, that “consuming foods containing ingredients derived from GM crops is no riskier than consuming the same foods containing ingredients from crop plants modified by conventional plant improvement techniques.” Major scientific and governmental organizations agree. The U.S. National Academy of Sciences found that “no adverse health effects attributed to genetic engineering have been documented in the human population,” and a report issued by the European Commission made the same claim. The World Health Organization has concluded that GM foods “are not likely, nor have been shown, to present risks for human health.”

What evidence will it take to convince the public that GM foods are as safe as non-GM foods?

The scientific literature backs this up. In February, the Journal of Agricultural and Food Chemistry published a literature review covering 20 years of safety studies. The authors found “overwhelming evidence” that using biotechnology to genetically modify crops “is less disruptive of crop composition compared with traditional breeding, which itself has a tremendous history of safety.” An overview of safety studies appearing this month in Nature Biotechnology noted that, despite disagreement over a need for more long-term safety studies, both critics and proponents of GMOs agree that so far “genetically modified foods have failed to produce any untoward health effects.”

In other words, the scientific consensus is that GMOs do not pose risks to our health or the environment that are any different from the risks posed by the non-GM crops created with modern breeding programs.

The discrepancy between the public debate over GM foods and the debate within the scientific community has left many scientists puzzling over the question: What evidence will it take to convince the public that GM foods are as safe as non-GM foods?

The editors at Nature Biotechnology argue that evidence is not the problem. The issue is that, so far, people have no reason to believe GM foods are being created for their benefit. Changing negative attitudes will “require a concerted and long-term effort to develop GM foods that clearly provide convincing benefits to consumers—something that seed companies have conspicuously failed to do over the past decade.” The question of benefits has been buried because the GMO debate has been framed around the unhelpful distinction between GM and non-GM foods. Instead of asking if GM foods in general are less safe, the editors argue, we should be focused on the specific risks and benefits of individual products, whether they are GM or not.

A focus on the risks and benefits of all new crops could move the debate in a direction that would prompt scientists, companies, and regulators to more clearly justify the role GMOs play in our food supply. To date, consumers nervous about GMOs have been given little reason to think that companies like Monsanto are designing GM crops to solve any problem other than the one of patents and profits. As journalist Mark Lynas put it in his rousing defense of GM foods, for most people GMOs are about a “big American corporation with a nasty track record, putting something new and experimental into our food without telling us.”

But many researchers working on GM crops are in fact trying to solve important problems, such as feeding a growing population, keeping food prices affordable worldwide, making healthier fruits and vegetables widely available, confronting the challenging growing conditions of a changing climate, saving Florida’s oranges or Hawaii’s papaya from pests, and fighting malnourishment in the developing world. For many of these problems, genetic engineering is faster, more cost-effective, and more reliable than conventional breeding methods.

Our society’s unresolved controversy over GMOs is not about safety; it’s about whether we have an acceptable process in place to ensure that our health is not put at risk for the sake of biotech’s bottom line. Researchers, biotech companies, and regulators need to settle on an appropriately rigorous, transparent, and independent safety testing process for all new crops, one whose methods and results are publicly available. Currently, as the Nature Biotechnology review notes, safety assessments in the U.S. are a patchwork affair with weak legal underpinnings. But for GM solutions to our food challenges to be widely accepted, the public needs to know that they are not being coerced into eating something whose risks and benefits are unknown.

Michael White
Michael White is a systems biologist at the Department of Genetics and the Center for Genome Sciences and Systems Biology at the Washington University School of Medicine in St. Louis, where he studies how DNA encodes information for gene regulation. He co-founded the online science pub The Finch and Pea. Follow him on Twitter @genologos.

More From Michael White

A weekly roundup of the best of Pacific Standard and PSmag.com, delivered straight to your inbox.

Recent Posts

October 31 • 4:00 AM

The Power of Third Person Plural on Support for Public Policies

Researchers find citizens react differently to policy proposals when they’re framed as impacting “people,” as opposed to “you.”


October 30 • 4:00 PM

I Should Have Told My High School Students About My Struggle With Drinking

As a teacher, my students confided in me about many harrowing aspects of their lives. I never crossed the line and shared my biggest problem with them—but now I wish I had.


October 30 • 2:00 PM

How Dark Money Got a Mining Company Everything It Wanted

An accidentally released court filing reveals how one company secretly gave money to a non-profit that helped get favorable mining legislation passed.


October 30 • 12:00 PM

The Halloween Industrial Complex

The scariest thing about Halloween might be just how seriously we take it. For this week’s holiday, Americans of all ages will spend more than $5 billion on disposable costumes and bite-size candy.


October 30 • 10:00 AM

Sky’s the Limit: The Case for Selling Air Rights

Lower taxes and debt, increased revenue for the city, and a much better use of space in already dense environments: Selling air rights and encouraging upward growth seem like no-brainers, but NIMBY resistance and philosophical barriers remain.


October 30 • 9:00 AM

Cycles of Fear and Bias in the Criminal Justice System

Exploring the psychological roots of racial disparity in U.S. prisons.


October 30 • 8:00 AM

How Do You Make a Living, Email Newsletter Writer?

Noah Davis talks to Wait But Why writer Tim Urban about the newsletter concept, the research process, and escaping “money-flushing toilet” status.



October 30 • 6:00 AM

Dreamers of the Carbon-Free Dream

Can California go full-renewable?


October 30 • 5:08 AM

We’re Not So Great at Rejecting Each Other

And it’s probably something we should work on.


October 30 • 4:00 AM

He’s Definitely a Liberal—Just Check Out His Brain Scan

New research finds political ideology can be easily determined by examining how one’s brain reacts to disgusting images.


October 29 • 4:00 PM

Should We Prosecute Climate Change Protesters Who Break the Law?

A conversation with Bristol County, Massachusetts, District Attorney Sam Sutter, who dropped steep charges against two climate change protesters.


October 29 • 2:23 PM

Innovation Geography: The Beginning of the End for Silicon Valley

Will a lack of affordable housing hinder the growth of creative start-ups?


October 29 • 2:00 PM

Trapped in the Tobacco Debt Trap

A refinance of Niagara County, New York’s tobacco bonds was good news—but for investors, not taxpayers.


October 29 • 12:00 PM

Purity and Self-Mutilation in Thailand

During the nine-day Phuket Vegetarian Festival, a group of chosen ones known as the mah song torture themselves in order to redirect bad luck and misfortune away from their communities and ensure a year of prosperity.


October 29 • 10:00 AM

Can Proposition 47 Solve California’s Problem With Mass Incarceration?

Reducing penalties for low-level felonies could be the next step in rolling back draconian sentencing laws and addressing the criminal justice system’s long legacy of racism.


October 29 • 9:00 AM

Chronic Fatigue Syndrome and the Brain

Neuroscientists find less—but potentially stronger—white matter in the brains of patients with CFS.


October 29 • 8:00 AM

America’s Bathrooms Are a Total Failure

No matter which American bathroom is crowned in this year’s America’s Best Restroom contest, it will still have a host of terrible flaws.



October 29 • 6:00 AM

Tell Us What You Really Think

In politics, are we always just looking out for No. 1?


October 29 • 4:00 AM

Racial Resentment Drives Tea Party Membership

New research finds a strong link between tea party membership and anti-black feelings.


October 28 • 4:00 PM

The New Health App on Apple’s iOS 8 Is Literally Dangerous

Design isn’t neutral. Design is a picture of inequality, of systems of power, and domination both subtle and not. Apple should know that.


October 28 • 2:00 PM

And You Thought Your Credit Card Debt Was Bad

In Niagara County, New York, leaders took on 40-year debt to pay for short-term stuff, a case study in the perverse incentives tobacco bonds create.



October 28 • 10:00 AM

How Valuable Is It to Cure a Disease?

It depends on the disease—for some, breast cancer and AIDS for example, non-curative therapy that can extend life a little or a lot is considered invaluable. For hepatitis C, it seems that society and the insurance industry have decided that curative therapy simply costs too much.


Follow us


We’re Not So Great at Rejecting Each Other

And it's probably something we should work on.

Chronic Fatigue Syndrome and the Brain

Neuroscientists find less—but potentially stronger—white matter in the brains of patients with CFS.

Incumbents, Pray for Rain

Come next Tuesday, rain could push voters toward safer, more predictable candidates.

Could Economics Benefit From Computer Science Thinking?

Computational complexity could offer new insight into old ideas in biology and, yes, even the dismal science.

Politicians Really Aren’t Better Decision Makers

Politicians took part in a classic choice experiment but failed to do better than the rest of us.

The Big One

One town, Champlain, New York, was the source of nearly half the scams targeting small businesses in the United States last year. November/December 2014

Copyright © 2014 by Pacific Standard and The Miller-McCune Center for Research, Media, and Public Policy. All Rights Reserved.